Clincosm LogoSign in Get a demo

Alzheimer Disease

Showing NaN - NaN of 56
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Alzheimer, Cognitive Dysfunction, Dementia Trial in Worldwide (JNJ-63733657, Placebo)

Recruiting
  • Alzheimer Disease
  • +2 more
  • Birmingham, Alabama
  • +143 more
Jan 31, 2023

Mild Cognitive Impairment, Alzheimer Trial in United States (Donanemab, Aducanumab)

Active, not recruiting
  • Mild Cognitive Impairment
  • Alzheimer Disease
  • Fullerton, California
  • +30 more
Jan 18, 2023

Alzheimer Trial in Worldwide (LY3372689, Placebo)

Active, not recruiting
  • Alzheimer Disease
  • Canoga Park, California
  • +70 more
Jan 18, 2023

Alzheimer Trial in New Haven (BMS-984923)

Completed
  • Alzheimer Disease
  • New Haven, Connecticut
    Yale University
Oct 4, 2022

Alzheimer Trial in New Haven ([18F]MNI-1020)

Completed
  • Alzheimer Disease
  • New Haven, Connecticut
    Invicro
Aug 17, 2022

Alzheimer Trial in Japan, Puerto Rico, United States (Donanemab, Placebo)

Recruiting
  • Alzheimer Disease
  • Birmingham, Alabama
  • +215 more
Aug 9, 2022

Alzheimer Trial in Worldwide (Gantenerumab, Placebo)

Active, not recruiting
  • Alzheimer Disease
  • Phoenix, Arizona
  • +156 more
Jul 4, 2022

Alzheimer Trial in Worldwide (Donanemab, Placebo)

Active, not recruiting
  • Alzheimer Disease
  • Hoover, Alabama
  • +282 more
Apr 6, 2022

Alzheimer Trial in United States (troriluzole, Placebo oral capsule)

Completed
  • Alzheimer Disease
  • Phoenix, Arizona
  • +43 more
Feb 15, 2022

Alzheimer Trial in New Haven (LPS)

Recruiting
  • Alzheimer Disease
  • New Haven, Connecticut
    Alzheimer's Disease Research Unit
Feb 8, 2022

Alzheimer Trial in Canada, United States (Azeliragon, Placebo)

Terminated
Has Results
  • Alzheimer Disease
  • Tucson, Arizona
  • +32 more
Dec 21, 2021

Alzheimer Trial in New Haven (Active Treatment- CT1812 100 mg, Placebo, Active Treatment- CT1812 300 mg)

Completed
  • Alzheimer Disease
  • Active Treatment- CT1812 100 mg
  • +2 more
  • New Haven, Connecticut
    Yale University School of Medicine
Jan 10, 2022

Alzheimer Trial in New Haven (Amyvid)

Recruiting
  • Alzheimer Disease
  • New Haven, Connecticut
    Invicro
Dec 7, 2021

Alzheimer Trial in New Haven ([18F]GTP1)

Completed
Has Results
  • Alzheimer Disease
  • [18F]GTP1
  • New Haven, Connecticut
    Invicro, a Konica Minolta company
Oct 5, 2021

Alzheimer, Healthy Volunteers Trial in New Haven ([18F] MNI-946, [18F]Florbetapir)

Completed
  • Alzheimer Disease
  • Healthy Volunteers
  • New Haven, Connecticut
    Invicro
Jun 10, 2021

Alzheimer, Parkinson Disease, Healthy Volunteers Trial in New Haven ([18F]MNI-1126)

Completed
  • Alzheimer Disease
  • +2 more
  • New Haven, Connecticut
    Invicro
Apr 13, 2020

Healthy Volunteers, Alzheimer, Progressive Supranuclear Palsy Trial in New Haven ([18F]MNI-958)

Completed
  • Healthy Volunteers
  • +2 more
  • New Haven, Connecticut
    Invicro
Feb 14, 2020

Alzheimer Trial in Canada, United States (Placebo Control, ELND005)

Completed
Has Results
  • Alzheimer Disease
  • Phoenix, Arizona
  • +61 more
Oct 17, 2019

Alzheimer Trial in New Haven (MNI-330 as a brain SPECT tracer of Beta-Amyloid)

Terminated
  • Alzheimer Disease
  • MNI-330 as a brain SPECT tracer of Beta-Amyloid
  • New Haven, Connecticut
    Institute for Neurodegenerative Disorders
Apr 1, 2019

Alzheimer, Parkinson Disease, Multiple Sclerosis Trial in New Haven ([18F] PBR06)

Terminated
  • Alzheimer Disease
  • +2 more
  • [18F] PBR06
  • New Haven, Connecticut
    Institute for Neurodegenerative Disorders
Apr 1, 2019

Parkinson Disease, Alzheimer, Healthy Controls Trial in New Haven ([123I]CLINDE)

Terminated
  • Parkinson Disease
  • +3 more
  • New Haven, Connecticut
    Institute for Neurodegenerative Disorders
Apr 1, 2019

Alzheimer, Healthy Volunteers, Progressive Supranuclear Palsy Trial in New Haven ([18F]MNI-958, [18F]Florbetapir, DaTscan)

Completed
  • Alzheimer Disease
  • +2 more
  • New Haven, Connecticut
    Molecular NeuroImaging, LLC
Mar 21, 2019

Alzheimer Trial in New Haven ([123I] AV-151)

Completed
  • Alzheimer Disease
  • [123I] AV-151
  • New Haven, Connecticut
  • +1 more
Mar 12, 2019

Progressive Supranuclear Palsy, Alzheimer, Healthy Volunteers Trial in New Haven ([18F]MNI-952, [18F]Florbetapir)

Completed
  • Progressive Supranuclear Palsy
  • +2 more
  • New Haven, Connecticut
    Molecular NeuroImaging, LLC
Oct 5, 2017

Parkinson Disease, Huntington Disease, Autistic Spectrum Disorders Trial in New Haven ([18F]FPEB)

Completed
  • Parkinson Disease
  • +5 more
  • New Haven, Connecticut
    Institute for Neurodegenerative Disorders
Jan 5, 2017